Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ly

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 20, 2016
Rifampin-Mediated Induction of Tamoxifen Metabolism in a Humanized PXR-CAR-CYP3A4/3A7-CYP2D6 Mouse ModelJae H Chang, John Chen, Liling Liu, et al.
Journal of Pharmaceutical Sciences|November 1, 2024
Vehicle effect on in-vitro and in-vivo performance of spray-dried dispersionsMarika Nespi, Justin Ly, Yuchen Fan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2015
Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitorEdna F Choo, Sarah Woolsey, Kevin DeMent, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2014
Differential effects of Rifampin and Ketoconazole on the blood and liver concentration of atorvastatin in wild-type and Cyp3a and Oatp1a/b knockout miceJae H Chang, Justin Ly, Emile Plise, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 2024
Human Pharmacokinetic and CYP3A Drug-Drug Interaction Prediction of GDC-2394 Using Physiologically Based Pharmacokinetic Modeling and Biomarker AssessmentJesse Yu, Fei Tang, Fang Ma, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 17, 2018
Unremarkable impact of Oatp inhibition on the liver concentration of fluvastatin, lovastatin and pitavastatin in wild-type and Oatp1a/1b knockout mouseJae H Chang, Xiaolin Zhang, Kirsten Messick, et al.
Biopharmaceutics & Drug Disposition|December 6, 2015
In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in ratsKaren E Parrish, Jialin Mao, Jacob Chen, et al.
The Journal of the Oklahoma State Medical Association|December 19, 2007
Longitudinal epiphyseal bracketJimmy Q Nguyen, Jason B Gatewood, Douglas Beall, et al.
Molecular Pharmaceutics|April 3, 2023
Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical StudiesCheng W Chiang, Joseph W Lubach, Tao Chen, et al.
Breast Cancer Research and Treatment|April 23, 2013
Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenograftsInna Y Gong, Wendy A Teft, Justin Ly, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 20, 2016
Rifampin-Mediated Induction of Tamoxifen Metabolism in a Humanized PXR-CAR-CYP3A4/3A7-CYP2D6 Mouse ModelJae H Chang, John Chen, Liling Liu, et al.
Journal of Pharmaceutical Sciences|November 1, 2024
Vehicle effect on in-vitro and in-vivo performance of spray-dried dispersionsMarika Nespi, Justin Ly, Yuchen Fan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2015
Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitorEdna F Choo, Sarah Woolsey, Kevin DeMent, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2014
Differential effects of Rifampin and Ketoconazole on the blood and liver concentration of atorvastatin in wild-type and Cyp3a and Oatp1a/b knockout miceJae H Chang, Justin Ly, Emile Plise, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 2024
Human Pharmacokinetic and CYP3A Drug-Drug Interaction Prediction of GDC-2394 Using Physiologically Based Pharmacokinetic Modeling and Biomarker AssessmentJesse Yu, Fei Tang, Fang Ma, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 17, 2018
Unremarkable impact of Oatp inhibition on the liver concentration of fluvastatin, lovastatin and pitavastatin in wild-type and Oatp1a/1b knockout mouseJae H Chang, Xiaolin Zhang, Kirsten Messick, et al.
Biopharmaceutics & Drug Disposition|December 6, 2015
In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in ratsKaren E Parrish, Jialin Mao, Jacob Chen, et al.
The Journal of the Oklahoma State Medical Association|December 19, 2007
Longitudinal epiphyseal bracketJimmy Q Nguyen, Jason B Gatewood, Douglas Beall, et al.
Molecular Pharmaceutics|April 3, 2023
Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical StudiesCheng W Chiang, Joseph W Lubach, Tao Chen, et al.
Breast Cancer Research and Treatment|April 23, 2013
Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenograftsInna Y Gong, Wendy A Teft, Justin Ly, et al.
Pageof 4